202 related articles for article (PubMed ID: 16710908)
1. Cetuximab plus radiotherapy for head and neck cancer.
Cengiz M; Yildiz F; Genc M
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710908
[No Abstract] [Full Text] [Related]
2. Cetuximab plus radiotherapy for head and neck cancer.
Ho AC
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16707760
[No Abstract] [Full Text] [Related]
3. Cetuximab plus radiotherapy for head and neck cancer.
Armstrong JG
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710907
[No Abstract] [Full Text] [Related]
4. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
Teoh DC; Rodger S; Say J; Hartley A
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
[No Abstract] [Full Text] [Related]
5. Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.
Chan A; Teoh D; Sanghera P; Hartley A
Radiother Oncol; 2009 Dec; 93(3):654. PubMed ID: 19524312
[No Abstract] [Full Text] [Related]
6. Cetuximab and radiotherapy for head and neck cancer.
Posner MR; Wirth LJ
N Engl J Med; 2006 Feb; 354(6):634-6. PubMed ID: 16467552
[No Abstract] [Full Text] [Related]
7. Cetuximab plus radiotherapy for head and neck cancer.
Hartig F; Pechlaner C
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710909
[No Abstract] [Full Text] [Related]
8. More on cetuximab in head and neck cancer.
Mell LK; Weichselbaum RR
N Engl J Med; 2007 Nov; 357(21):2201-2; author reply 2202-3. PubMed ID: 18032774
[No Abstract] [Full Text] [Related]
9. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
Bonner JA; Harari PM; Giralt J; Cohen RB; Jones CU; Sur RK; Raben D; Baselga J; Spencer SA; Zhu J; Youssoufian H; Rowinsky EK; Ang KK
Lancet Oncol; 2010 Jan; 11(1):21-8. PubMed ID: 19897418
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA; Harari PM; Giralt J; Azarnia N; Shin DM; Cohen RB; Jones CU; Sur R; Raben D; Jassem J; Ove R; Kies MS; Baselga J; Youssoufian H; Amellal N; Rowinsky EK; Ang KK
N Engl J Med; 2006 Feb; 354(6):567-78. PubMed ID: 16467544
[TBL] [Abstract][Full Text] [Related]
11. Concomitant chemoradiation for head and neck cancer: saving lives or grays?
Henk JM
Clin Oncol (R Coll Radiol); 2001; 13(5):333-5. PubMed ID: 11716224
[No Abstract] [Full Text] [Related]
12. Are anti-vitamin K drugs contraindicated with cetuximab during head-and-neck cancer concomitant radiotherapy?
Brohée D; Henry AR; Castadot P
Acta Clin Belg; 2013; 68(3):237-9. PubMed ID: 24156231
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab in squamous cell head and neck carcinomas.
Gebbia V; Giuliani F; Valori VM; Agueli R; Colucci G; Maiello E
Ann Oncol; 2007 Jun; 18 Suppl 6():vi5-7. PubMed ID: 17591832
[TBL] [Abstract][Full Text] [Related]
14. Manageable early toxicity of cetuximab concurrent with radical radiotherapy for locally advanced head and neck cancer.
Wieczorek A; Hamid A; O'Toole L
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):496. PubMed ID: 21482459
[No Abstract] [Full Text] [Related]
15. [Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases].
Xia LP; Zhang B; Liu MZ; Hu PL; Chen XX; Guo GF; Qiu HJ; Rong YM; Qian SY; Zhou FF; Huang YY; Wang TL
Ai Zheng; 2009 Sep; 28(9):977-82. PubMed ID: 19728918
[TBL] [Abstract][Full Text] [Related]
16. Acneiform rash secondary to cetuximab plus head and neck radiotherapy.
Mydin AR; Armstrong JG
Radiother Oncol; 2007 Oct; 85(1):171. PubMed ID: 17531339
[No Abstract] [Full Text] [Related]
17. Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.
Balermpas P; Hambek M; Seitz O; Rödel C; Weiss C
Strahlenther Onkol; 2009 Dec; 185(12):775-81. PubMed ID: 20013086
[TBL] [Abstract][Full Text] [Related]
18. [Oncological treatment modalities in head and neck cancer].
Saarilahti K; Lindholm P
Duodecim; 2011; 127(18):1979-85. PubMed ID: 22034736
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced head and neck cancer with cetuximab.
Merlano M; Garrone O
Int J Biol Markers; 2007; 22(1 Suppl 4):S71-6. PubMed ID: 17520584
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab-induced pneumonitis in head and neck cancer patient.
De Vos FY; Driessen CM; Jaspers HC; van Herpen CM; Simons B
Oral Oncol; 2012 Jun; 48(6):e17-8. PubMed ID: 22342570
[No Abstract] [Full Text] [Related]
[Next] [New Search]